Latest Stock Market News

The overall subscription stood at 18.78x so far. The categories reserved for NII and QIB investors were subscribed 34 times and 21 times, respectively. Meanwhile, the retail portion of the issue was subscribed the least at 10.54 times.

​A passive fund makes more sense because you have only 15 stocks that sort of qualify for this index and we hope to have a lot more stocks that qualify for this index in the future.

PSU banks are currently showing strong loan growth compared to private peers. PNB reported a significant increase in loan growth from the previous quarter. According to Rahul Malani of Sharekhan, analysts foresee a positive trajectory for PSU banks driven by solid loan growth and a favorable credit environment in FY25.

Definitely, yesterday there were very-very clear signs of pharma just shooting up and that is a clear indication that yes, most of the stocks in pharma can do good. In fact, if you see stocks like Lupin, Sun Pharma, all these are breaking out of their last six-seven years kind of a consolidation and people who have bought them six-seven years back, they are still not even finding their price.

The Relative Strength Index of the stock stood at 73.97 on Friday.

In a rapidly rising market, evaluating stocks that offer exceptional returns for investors can pose challenges.

Promoters held 62.55 per cent stake in the company as of 31-Mar-2024, while FII and DII ownership stood at 12.48 per cent and 7.55 per cent, respectively.

Emcure Pharmaceuticals IPO sees strong demand with oversubscription. Anchor investors include top names. Company engaged in global pharmaceutical products. Revenue growth and plans for debt payment outlined. Book-running lead managers identified.

Nile is majority-owned by the promoters with 50.43% stake, while public shareholders own the rest of 49.57%. Among the public shareholders, mutual funds and foreign investors have negligible holdings.